News

Elderly patient with heart failure and preserved ejection fraction: effects of ivabradine

30.09.20131847

Approximately half of patients with a diagnosis of heart failure have a normal left ventricular ejection fraction. This patients are usually older, female and with comorbidities such as hypertension, diabetes and renal failure.

Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes

27.09.20131902

The aim of the current study was to evaluate the diagnostic and intermediate-term prognostic impact of C-terminal portion of provasopressin (copeptin) in combination with troponin I.

Exercise training is safe after coronary stenting: a prospective multicentre study

26.09.20131658

Data on the safety of exercise training after coronary stenting are scarce.

Biomarker IDs Fibrotic Heart Failure

25.09.20131778

Galectin-3 (Gal-3), a biomarker for fibrosis, may have a role in identifying heart failure caused by cardiac amyloidosis, researchers suggested.

Association of Statin Use With CataractsA Propensity Score–Matched Analysis

24.09.20131840

Cataracts are a main cause of low vision; with the growing elderly population, the incidence of cataracts is likely to increase. Investigators have previously hypothesized that statin antioxidant effects may slow the natural aging process of the lens.

Infective Endocarditis in Children With Congenital Heart Disease Cumulative Incidence and Predictors

24.09.20131770

The American Heart Association guidelines for prevention of infective endocarditis (IE) in 2007 reduced the groups of congenital heart disease (CHD) patients for whom antibiotic prophylaxis was indicated.

Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure

20.09.20131823

Clinical guidelines recommend digoxin for patients with symptomatic systolic heart failure (HF) receiving optimal medical therapy, but this recommendation is based on limited, older trial data. We evaluated the effectiveness and safety of digoxin in a contemporary cohort of patients with incident systolic HF.